Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  diphenhydramine hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-19 of 19 for your search:
Start Over
Phase III Adjuvant Chemotherapy with Intravesical ADR Alone and in Combination with Systemic cis-Platinum and 5-FU in Adult Patients with Superficial Bladder Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSUCTC-8417, NCI-V85-0102
Phase III Study of Sucralfate Suspension vs Maalox/Benadryl/Viscous Lidocaine Cocktail to Treat Therapy-Associated Mucositis in Cancer Patients (Summary Last Modified 05/92)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: ICC-88CCN1, NCI-P89-0013, NCI-C88-0010
Phase II Chemotherapy with Neocarzinostatin for Advanced Metastatic Urothelial Bladder Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-7757
Phase II Chemotherapy with Rubidazone for Children with Refractory Acute Lymphoblastic or Acute Myelogenous Leukemia
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: POG-7818, MDAR-313
Phase II Chemotherapy with Neocarzinostatin for Acute Lymphocytic or Acute Nonlymphocytic Leukemia in Children
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and under
Sponsor: NCI
Protocol IDs: POG-7831, MDAR-319
Phase II Chemotherapy with Rubidazone for Lymphoma in Relapsing Patients Previously Untreated with Anthracycline Derivatives
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7734
Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Gastric Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8120
Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Hodgkin's Disease and non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8116
Phase II Chemotherapy with Bisantrene Hydrochloride for Refractory Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8118
Phase II Chemotherapy with Bisantrene Hydrochloride for Advanced Hepatoma in Relapse
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8119
Phase II Pilot Chemotherapy with Bisantrene Hydrochloride in Adults with Refractory Acute Leukemia
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: SWOG-8161
Phase II Combination Chemotherapy (CTX/VCR/ACT-D or VBL/BLEO/CDDP) and/or Radiotherapy for Malignant Germ Cell Tumors in Children
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 20
Sponsor:
Protocol IDs: SJCRH-GCT-79
CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00047, CDR0000365314, NCI-6199, 12983A, 6199, N01CM62201, N01CM62202, P30CA014599, NCT00290472
Phase I Chemotherapy with Taxol for Carcinoma, Lymphoma, or Sarcoma
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: DFCI-83092, NCI-T84-0194W, T84-0194
Induction by AZC/RBD and Maintenance by Repetitive Sequences of AZC/RBD, AZC/CTX, AZC/TG, AZC/VCR/DM for Acute Myelocytic Leukemia
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-7703
Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-13108, NCI-2010-01968, PEP-10-174-1-PCSM, NCT01204255
Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Patients With Nausea
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-14141, NCI-2012-00220, NCT01556932
Start Over